HK Stock MarketDetailed Quotes
06618 JD HEALTH
- 23.250
- +0.150+0.65%
Not Open Apr 18 16:08 CST
74.15BMarket Cap31.38P/E (TTM)
23.750High22.600Low5.75MVolume22.950Open23.100Pre Close133.91MTurnover0.18%Turnover Ratio31.38P/E (Static)3.19BShares59.60052wk High1.36P/B74.15BFloat Cap22.60052wk Low--Dividend TTM3.19BShs Float198.500Historical High--Dividend LFY4.98%Amplitude22.600Historical Low23.303Avg Price50Lot Size--Div YieldTTM--Div Yield LFY
JD HEALTH Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 14.54%53.53B | 34.04%27.11B | --13.95B | 52.32%46.74B | 48.30%20.23B | 58.30%30.68B | 55.37%13.64B | 78.77%19.38B | 75.95%8.78B | 32.72%10.84B |
| Operating income | 14.54%53.53B | 34.04%27.11B | 52.32%46.74B | 48.30%20.23B | 58.30%30.68B | 55.37%13.64B | 78.77%19.38B | 75.95%8.78B | 32.72%10.84B | |
| Cost of sales | -13.08%-41.66B | -32.24%-20.91B | ---- | -56.89%-36.84B | -53.05%-15.81B | -62.35%-23.48B | -57.48%-10.33B | -80.14%-14.47B | -79.39%-6.56B | -29.72%-8.03B |
| Operating expenses | -13.08%-41.66B | -32.24%-20.91B | -56.89%-36.84B | -53.05%-15.81B | -62.35%-23.48B | -57.48%-10.33B | -80.14%-14.47B | -79.39%-6.56B | -29.72%-8.03B | |
| Gross profit | 19.95%11.87B | 40.51%6.2B | 37.43%9.89B | 33.47%4.41B | 46.37%7.2B | 49.15%3.31B | 74.85%4.92B | 66.52%2.22B | 42.11%2.81B | |
| Selling expenses | -20.91%-2.65B | -28.03%-1.19B | ---- | -2.90%-2.2B | 4.59%-933.3M | -48.74%-2.13B | -79.69%-978.18M | -92.30%-1.43B | -111.37%-544.38M | -90.40%-746.01M |
| Administrative expenses | 7.20%-2B | 11.09%-876.78M | ---- | 15.12%-2.15B | 12.17%-986.16M | -381.25%-2.54B | -1,226.44%-1.12B | -322.01%-527.19M | -27.65%-84.65M | 6.67%-124.92M |
| Research and development expenses | -14.93%-1.23B | -26.72%-616.86M | ---- | -19.52%-1.07B | -21.16%-486.8M | -46.60%-892.91M | -44.44%-401.79M | -80.07%-609.07M | -84.35%-278.18M | -54.96%-338.24M |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,288.60%-17.54B | ---5.71B | ---1.26B |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,288.60%-17.54B | ---5.71B | ---1.26B |
| Impairment and provision | 28.86%-69.86M | -486.50%-64.66M | ---- | -156.05%-98.2M | -12.15%-11.03M | -32,679.49%-38.35M | -2,161.01%-9.83M | 93.71%-117K | 150.85%477K | 57.62%-1.86M |
| -Other impairment is provision | 28.86%-69.86M | -486.50%-64.66M | ---- | -156.05%-98.2M | -12.15%-11.03M | -32,679.49%-38.35M | -2,161.01%-9.83M | 93.71%-117K | 150.85%477K | 57.62%-1.86M |
| Operating interest expense | -4.24%-9.49M | 9.97%-4.39M | ---- | -51.68%-9.1M | -102.28%-4.87M | -75.61%-6M | -38.05%-2.41M | 90.38%-3.42M | -2,054.32%-1.75M | -23,568.00%-35.5M |
| Special items of operating profit | 12.11%-3.14B | -0.99%-1.58B | ---- | -49.19%-3.58B | -42.77%-1.57B | -33.27%-2.4B | -28.70%-1.1B | -58.11%-1.8B | -63.67%-852.57M | -23.05%-1.14B |
| Operating profit | 248.75%2.76B | 337.51%1.86B | 795.45M | 198.17%792.57M | 239.75%425.91M | 95.25%-807.33M | 94.19%-304.77M | -1,936.07%-17B | -1,666.83%-5.25B | -372.57%-834.7M |
| Share of profits of associates | 26.87%-70.76M | 33.70%-32.2M | ---- | -2.75%-96.76M | -19.82%-48.57M | -22.25%-94.17M | ---40.53M | ---77.02M | ---- | ---- |
| Share of profit from joint venture company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---8.61M | ---- |
| Earning before tax | 287.08%2.69B | 385.29%1.83B | 177.18%695.81M | 209.28%377.35M | 94.72%-901.49M | 93.43%-345.3M | -1,945.30%-17.07B | -1,669.40%-5.26B | -372.57%-834.7M | |
| Tax | -76.10%-550.47M | -74.39%-269.23M | ---- | -82.45%-312.58M | -41.76%-154.39M | -5.27%-171.33M | -5.14%-108.91M | -18.71%-162.76M | -4.92%-103.59M | -50.16%-137.11M |
| After-tax profit from continuing operations | 459.16%2.14B | 600.58%1.56B | 135.72%383.23M | 149.09%222.96M | 93.78%-1.07B | 91.53%-454.21M | -1,673.49%-17.23B | -2,369.13%-5.36B | -552.16%-971.81M | |
| Earning after tax | 459.16%2.14B | 600.58%1.56B | 135.72%383.23M | 149.09%222.96M | 93.78%-1.07B | 91.53%-454.21M | -1,673.49%-17.23B | -2,369.13%-5.36B | -552.16%-971.81M | |
| Minority profit | -66.74%1.04M | 206.73%634K | ---- | 353.41%3.12M | -163.80%-594K | 229.03%689K | 143.04%931K | ---534K | ---2.16M | ---- |
| Profit attributable to shareholders | 463.49%2.14B | 598.43%1.56B | 135.41%380.11M | 149.12%223.55M | 93.77%-1.07B | 91.51%-455.14M | -1,673.44%-17.23B | -2,368.22%-5.36B | -552.16%-971.81M | |
| Basic earnings per share | 475.00%0.69 | 614.29%0.5 | 134.29%0.12 | 146.67%0.07 | 95.51%-0.35 | 93.98%-0.15 | -1,633.33%-7.8 | -2.49 | -0.45 | |
| Diluted earnings per share | 466.67%0.68 | 600.00%0.49 | 134.29%0.12 | 146.67%0.07 | 95.51%-0.35 | 93.98%-0.15 | -1,633.33%-7.8 | -2.49 | -0.45 | |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | Deloitte & Touche Tohmatsu Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg